The antiviral combination of nirmatrelvir and ritonavir (brand name Paxlovid) is an effective treatment for people with COVID ...

LONDON - Shionogi & Co., Ltd. (TYO:4507) has reported positive outcomes from its Phase 2a human challenge trial for an investigational oral antiviral candidate targeting Respiratory Syncytial Virus ...

Pittsburgh’s Action News 4 anchor Kristen Powers sat down with infectious disease expert Dr. Amesh Adalja during a recent episode of "4 The Record" to discuss the benefits of antivirals. The ...

Medicines, such as antivirals and vaccines, which had more solid evidence showing they were effective compared to other types of safety measures, were ...

New research showed some long COVID patients get symptom relief by taking an extended course of Paxlovid. Data are ...

Yes—but at a slightly smaller dose than teens and adults. Children who are 2 weeks to 12 years old take a twice-daily dose ...

Existing treatment criteria for chronic hepatitis B virus (HBV) infection are mainly based on data from observational studies, such as the REVEAL study from Taiwan, which was initiated in the early ...

Knowing when to seek treatment at urgent care vs. emergency department helps alleviate strain on healthcare system and ensure ...

Flu symptoms can be notoriously difficult to shake, but drinking one tea could shorten the duration of your illness ...

In a new clinical practice guideline, the AGA provided evidence-based recommendations for either antiviral prophylaxis or continued surveillance to manage hepatitis B virus reactivation in patients ...

The American Gastroenterology Association (AGA) updated its clinical practice guidelines for managing hepatitis B ...

Invivyd (IVVD) announced positive data from its ongoing Phase 1/2 clinical trial of VYD2311, Invivyd’s novel monoclonal antibody candidate ...